Viewing nowCombinationNexium 20 mg Tablets (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 21.69mg · Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.

MFDS item code 201508404 · Approved 2015.12.23 · Insurance code 656004080
Treatment of acid-related disorders (reflux, ulcers, Zollinger-Ellison syndrome, etc.), H. pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive esophagitis, and to prevent recurrence in patients with esophagitis. It also helps alleviate symptoms of gastroesophageal reflux disease without esophagitis. It is used for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers in patients with Helicobacter pylori infection, and is effective for the treatment and prevention of gastrointestinal symptoms and gastric ulcers or duodenal ulcers caused by non-steroidal anti-inflammatory drugs. It is also used in maintenance therapy to prevent re-bleeding of gastric ulcers or duodenal ulcers and for the treatment of Zollinger-Ellison syndrome. Overall, it is used to relieve symptoms, treat, and prevent recurrence of gastrointestinal-related diseases.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Adults Gastroesophageal reflux disease (GERD) — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. Combination therapy with antibiotics for eradication of Helicobacter pylori: Administer 20 mg of this medicine with 1 g of amoxicillin and 500 mg of clarithromycin twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning) associated with NSAID (nonselective or selective COX-2 inhibitor) use: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. Patients requiring continued NSAID therapy — Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome: The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration: Administer 40 mg once daily for 4 weeks following intravenous administration to induce prevention of rebleeding due to gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. Older adults: No dose adjustment is necessary.
Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older — Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. Adolescents aged 12 years and older — In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. Children under 12 years of age — There is no experience with administering this medicine to children under 12 years of age.
This medication should not be used in patients with allergic reactions or hypersensitivity to certain antibiotics. Especially, nursing women or patients with a history of heart disease should avoid administration. This medication contains lactose, so it is not suitable for patients with lactose intolerance. Rarely, a variety of side effects such as blood abnormalities, allergic reactions, neurological symptoms, gastrointestinal disorders may occur during use; if abnormal symptoms occur, consult a physician immediately. Regular check-ups are needed for long-term use, and monitoring of magnesium levels is particularly important. This medication may interact with other drugs; be sure to inform your doctor of any medications being taken. Safety during pregnancy has not been fully confirmed, so caution is needed, and it is advisable not to use it during breastfeeding. In case of overdose, there is no specific antidote, so appropriate treatment should be administered according to symptoms. Keep out of reach of children and do not transfer to other containers.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, mucositis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid nodules, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, agitation, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disturbances, tremors, dizziness, visual field defects, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, olfactory disturbances, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcers, esophageal varices, gastric ulcers, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is preferable to maintain a storage temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication over time.
For domestic use: round enteric-coated tablets in light pink; for export: round film-coated tablets in pink
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEsomeprazole Magnesium Trihydrate 21.69mg · Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.